Skip to main content
Log in

Urine-based TB screening cost effective in Africa

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 US dollars

References

  1. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. The Lancet Global Health : 29 Jan 2019. Available from: URL: https://doi.org/10.1016/S2214-109X(18)30436-4

  2. Zwerling A. Costs of tuberculosis screening among inpatients with HIV. The Lancet Global Health 7: e163-e164, No. 2, Feb 2019. Available from: URL: https://doi.org/10.1016/S2214-109X(18)30564-3

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Urine-based TB screening cost effective in Africa. PharmacoEcon Outcomes News 821, 33 (2019). https://doi.org/10.1007/s40274-019-5650-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5650-y

Navigation